Community Based Screening for Colorectal Cancer in an Underserved High Risk Population in Nigeria
NCT ID: NCT03032874
Last Updated: 2017-01-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2014-01-01
2016-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Building Capacity for Screening & Early Diagnosis of Colorectal Cancer Through a Comprehensive Colonoscopy Training Program in Nigeria
NCT05686499
Barriers to Care in Patients With Rectal Bleeding in Nigeria
NCT02855385
Point of Care Test to Diagnosed Colorectal Cancer and Polyps in Low Middle Income Countries
NCT03173729
Increasing Colorectal Cancer Screening in African Americans
NCT00893295
Addressing Colorectal Cancer in South Florida Firefighters
NCT05976282
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Training set
All the patients with rectal bleeding who had colonoscopy performed at Obafemi Awolowo University Teaching Hospitals Complex
Colonoscopy
They all had screening colonoscopy
Validation set
All the patients with rectal bleeding who had colonoscopy performed at University College Hospital, Ibadan and University of Ilorin Teaching Hospital
Colonoscopy
They all had screening colonoscopy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Colonoscopy
They all had screening colonoscopy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* has rectal bleeding lasting at least one week
* has had a complete colonoscopy performed
Exclusion Criteria
* Individuals with a family history of familial adenomatous polyposis syndromes or other hereditary polyposis syndromes, hereditary nonpolyposis colorectal cancer
* Individuals with severe comorbidities that were contraindication to colonoscopy
* Individuals who had a previous history of colectomy
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Memorial Sloan Kettering Cancer Center, New York, USA
UNKNOWN
University College Hospital, Nigeria
UNKNOWN
University of Ilorin Teaching Hospital
OTHER
Obafemi Awolowo University Teaching Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Olusegun Alatise
Consultant Surgeon/Senior Lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Endoscopy Unit, Obafemi Awolowo University Teaching Hospitals
Ile-Ife, Osun State, Nigeria
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Alatise OI, Ayandipo OO, Adeyeye A, Seier K, Komolafe AO, Bojuwoye MO, Afuwape OO, Zauber A, Omisore A, Olatoke S, Akere A, Famurewa O, Gonen M, Irabor DO, Kingham TP. A symptom-based model to predict colorectal cancer in low-resource countries: Results from a prospective study of patients at high risk for colorectal cancer. Cancer. 2018 Jul 1;124(13):2766-2773. doi: 10.1002/cncr.31399. Epub 2018 Apr 12.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ERC/2013/02/07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.